ABX-002: A fatty-acid amide hydrolase (FAAH) activated prodrug enhances functional delivery of a potent TR-β selective thyromimetic to the brain and demonstrates biological activity in models of X-linked Adrenoleukodystrophy (2442)

To investigate the preclinical efficacy ABX-002 in models of target engagement and remyelination relevant to X-linked Adrenoleukodystrophy (X-ALD).